This inventor holds 2 USPTO granted patents. Top assignee: Elan Pharmaceuticals, Inc.. Active years: 2000-2001.
Location History:
- Los Altos Hills, CA (US) (2000)
- Reno, NV (US) (2001)
Company Filing History:
Years Active: 2000-2001
Title: The Innovations of Robert R Luther
Introduction
Robert R Luther is a notable inventor based in Reno, NV (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative methods for drug administration. With a total of 2 patents, Luther's work focuses on improving patient care through advanced medical techniques.
Latest Patents
Luther's latest patents include the "Transdermal administration of fenoldopam" and the "Epidural method of producing analgesia." The first patent describes a method for the transdermal administration of both the racemic mixture and the active R-fenoldopam enantiomer. This innovation includes the development of transdermal patches that provide therapeutically effective delivery of fenoldopam to patients suffering from impaired renal function or hypertension. The second patent presents an improved method for treating pain by administering an N-type voltage-sensitive calcium channel blocking omega conopeptide. This method is characterized by its ability to inhibit electrically stimulated contraction of the guinea pig ileum and selectively bind to omega conopeptide MVIIA binding sites in neuronal tissue. The administration of this compound is preferably done epidurally, ensuring prolonged contact with the epidural region.
Career Highlights
Robert R Luther is associated with Elan Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical industry. His work has been instrumental in advancing pain management and renal treatment methodologies.
Collaborations
Luther has collaborated with notable colleagues such as David J Ellis and Mark Raymond Pettus, contributing to the development of groundbreaking medical solutions.
Conclusion
Robert R Luther's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving patient outcomes. His work continues to influence the medical community and enhance treatment options for various conditions.